Table S4 from Site-Specific Dolasynthen Antibody–Drug Conjugates Exhibit Consistent Pharmacokinetic Profiles across a Wide Range of Drug-to-Antibody Ratios

• DOI: 10.1158/1535-7163.24935455.v1
• Publication Date: 2024-01-03T08:22:18Z
• Authors: Susan M. Clardy; Alex Uttard; Bingfan Du; Kalli C. Catcott; Kelly L. Lancaster; Elizabeth Ditty; Jack Sadowsky; Jeffrey Zurita; Naniye Malli; LiuLiang Qin; Stephen P. Bradley; Kenneth Avocetien; Tyler Carter; Dokyong Kim; Mark Nazzaro; Ling Xu; Thomas H. Pillow; Neelie T. Zacharias; Gail D. Lewis; Rebecca K. Rowntree; Radha Iyengar; David H. Lee; Marc Damelin; Dorin Toader; Timothy B. Lowinger
• Keywords: Table (database); Antibody-drug conjugate; Conjugate

<p>Table S4 compares the nominal DAR to calculated values from measured Cmax for each ADC</p>